Arthritis: Clinical Trials

580 trials for Arthritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

580 completed. 580 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4580Completed 580

Follow Arthritis: new trials by email Literature Review of Arthritis trials Research Report on Arthritis

Trials (filtered) newest first · largest first

All 580 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
EFFECT OF INTRAARTICULAR TRIAMCINOLONE HEXACETONIDE AND BETAMETHASONE ON INTRAOCULAR PRESSURE
Diprospan, artropan - Knee Osteoarthritis (Knee OA), Intraocular Pressure
Phase 4CompletedNigde Omer Halisdemir University802025-10-022025-11-21
Impact of Dexamethasone Route on Pain and Inflammation in iPACK With ACB for Knee Arthroplasty
NaCl 0.9%, Dexamethasone 4mg - Osteoarthritis, Knee, Knee Pain Chronic
Phase 4CompletedPoznan University of Medical Sciences902025-09-132026-05-22
PENG Block Optimization: Volume and Dexamethasone Effects
Ropivacaine 0.2% Injectable Solution, Dexamethasone 4mg - Hip Arthropathy, Hip Osteoarthritis
Phase 4CompletedPoznan University of Medical Sciences1202025-06-252026-03-16
NLR and PLR Levels Following PENG Block in Hip Arthroplasty
0.9% Sodium Chloride Injection, Ropivacaine 0.2% Injectable Solution - Hip Arthropathy, Hip Osteoarthritis
Phase 4CompletedPoznan University of Medical Sciences602025-06-162025-12-29
The Effect of Dexamethasone Administration Route on Pain and Inflammatory Response in PENG Block for Total Hip Arthroplasty
perineural Dexamethasone 4mg, intravenous Dexamethsone 4mg - Osteoarthritis, Hip, Hip Pain Chronic
Phase 4CompletedPoznan University of Medical Sciences602025-02-012025-07-23
Dexamethasone for ESPB in Total Hip Arthroplasty
0.9%NaCl, Dexamethasone 4mg - Hip Osteoarthritis, Hip Arthropathy
Phase 4CompletedPoznan University of Medical Sciences602025-02-012025-07-23
Two-level ESPB in Total Knee Arthroplasty
2 x 20 ml of Ropivacaine 0.2% Injectable Solution, 2 x 20ml of Ropivacaine 0.2% Injectable Solution - Knee Osteoarthritis, Knee Pain Chronic
Phase 4CompletedPoznan University of Medical Sciences602024-11-072025-11-25
Dexamethasone With Ropivacaine for PENG Block in Total Hip Arthroplasty
Ropivacaine, Ropivacaine+Dexamethasone - Hip Osteoarthritis, Hip Pain Chronic
Phase 4CompletedPoznan University of Medical Sciences602024-11-072025-07-11
A Study of Filgotinib in Korean Participants With Rheumatoid Arthritis
Filgotinib Maleate - Rheumatoid Arthritis
Phase 4CompletedEisai Korea Inc.1182024-10-222026-05-11
Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Knee Arthroplasty
0.9% Sodium Chloride Injection, Dexamethasone, Dexmedetomidine - Knee Osteoarthritis, Knee Arthritis
Phase 4CompletedPoznan University of Medical Sciences902024-08-132026-03-30
Dexamethasone for iPACK Block With ACB in Total Knee Arthroplasty
Ropivacaine, Ropivacaine+Dexamethasone - Knee Osteoarthritis, Knee Pain Chronic
Phase 4CompletedPoznan University of Medical Sciences602024-08-132025-07-23
Dexamethasone for PENG Block in Total Hip Arthroplasty
Ropivacaine 0.2% Injectable Solution, Ropivacaine 0.2% Injectable Solution + 4mg Dexamethasone - Hip Osteoarthritis, Hip Arthropathy
Phase 4CompletedPoznan University of Medical Sciences602024-08-132025-03-24
Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Hip Arthroplasty
0.9%sodium chloride, Dexamethasone, Dexmedetomidine - Hip Osteoarthritis, Hip Arthropathy
Phase 4CompletedPoznan University of Medical Sciences902024-04-102026-11-06
NLR and PLR Levels Following IPACK Block in Knee Arthroplasty
0.9% Sodium Chloride Injection, Ropivacaine 0.2% Injectable Solution - Knee Arthropathy, Knee Osteoarthritis
Phase 4CompletedPoznan University of Medical Sciences602024-03-302025-03-24
Erector Spinae Plane Block Vs. IPACK Block with Adductor Canal Block for Total Knee Arthroplasty
Control Test - spinal anesthesia, Ropivacaine 0.2% Injectable Solution ESPB, Ropivacaine 0.2% Injectable Solution iPACK+ACB - Knee Osteoarthritis, Knee Pain Chronic
Phase 4CompletedPoznan University of Medical Sciences902024-03-302024-09-26
A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout
Pegloticase, Methotrexate - Gout
Phase 4CompletedAmgen3062024-03-182026-09-17
ESPB vs iPACK+ACB in Total Knee Arthroplasty
Ropivacaine 0.2% Injectable Solution, control group - Knee Arthritis, Knee Arthropathy
Phase 4CompletedPoznan University of Medical Sciences602024-03-082026-11-06
Comparative Study of Leflunomide Plus Methotrexate Versus Methotrexate Monotherapy in Refractory Polyarticular Juvenile Idiopathic Arthritis Patients
Leflunomide plus Methotrexate, Methotrexate Monotherapy - Juvenile Idiopathic Arthritis, Polyarticular Juvenile Idiopathic Arthritis
Phase 4CompletedBangladesh Medical University502024-03-012026-02-23
Postoperative Pain and Analgesic Requirements After Preoperative Methadone for Primary TKA
Preoperative Methadone, Preoperative Oxycodone - Osteoarthritis (OA) of the Knee
Phase 4CompletedUniversity of Louisville1502024-02-192024-11-15
Collagen-PVP vs Hylan G-F 20 in the Treatment of Knee Osteoarthritis
Collagen-polyvinylpyrrolidone, Hylan G-F 20 - Osteoarthritis (OA) of the Knee
Phase 4CompletedCentro Multidisciplinario para el Desarrollo Especializado de la Investigacion Clinica en Yucatan S.322024-01-232026-07-09

Showing 20 of 580. Sign in to see all of them.

Narrower conditions

Arthritis, Rheumatoid (191)  ·  Osteoarthritis (146)  ·  Osteoarthritis, Knee (127)  ·  Osteoarthritis, Hip (36)  ·  Spondylitis, Ankylosing (32)  ·  Pain (31)  ·  Arthritis, Psoriatic (24)  ·  Gout (19)  ·  Arthritis, Juvenile (14)  ·  Pain, Postoperative (11)  ·  Chronic Pain (10)  ·  Spondylarthritis (10)  ·  Joint Diseases (9)  ·  Sjogren's Syndrome (9)

Broader conditions

Musculoskeletal Diseases (579)  ·  Joint Diseases (571)  ·  Rheumatic Diseases (498)  ·  Skin and Connective Tissue Diseases (242)  ·  Connective Tissue Diseases (216)  ·  Immune System Diseases (215)  ·  Autoimmune Diseases (212)  ·  Osteoarthritis (134)  ·  Bone Diseases (87)  ·  Pathological Conditions, Signs and Symptoms (86)  ·  Spinal Diseases (70)  ·  Spondylitis (68)  ·  Signs and Symptoms (67)  ·  Neurologic Manifestations (60)

Interventions

Methotrexate (67)  ·  Etanercept (55)  ·  Adalimumab (42)  ·  Sodium Chloride (29)  ·  tocilizumab (26)  ·  Celecoxib (23)  ·  Infliximab (23)  ·  Ropivacaine (23)  ·  Dexamethasone (17)  ·  Rituximab (15)  ·  Saline Solution (15)  ·  Abatacept (14)  ·  Hyaluronic Acid (13)  ·  Sulfasalazine (12)  ·  Acetaminophen (11)

Sponsors

Hoffmann-La Roche (24)  ·  Amgen (22)  ·  Poznan University of Medical Sciences (19)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (15)  ·  Ewha Womans University (14)  ·  Pfizer (13)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (10)  ·  Hospital for Special Surgery, New York (8)  ·  Merck Sharp & Dohme LLC (7)  ·  Sanofi (7)  ·  Brigham and Women's Hospital (6)  ·  Chinese University of Hong Kong (6)  ·  DePuy International (6)  ·  Federal University of São Paulo (6)  ·  Seoul National University Hospital (6)

Countries

United States (147)  ·  South Korea (48)  ·  France (45)  ·  Germany (42)  ·  United Kingdom (42)  ·  Canada (37)  ·  Denmark (37)  ·  Poland (36)  ·  Italy (33)  ·  Spain (32)  ·  China (30)  ·  Netherlands (26)  ·  Brazil (22)  ·  Belgium (20)  ·  Australia (18)

Top investigators

Young-Hoo Kim, MD (7)  ·  Malgorzata Reysner, M.D. Ph.D. (6)  ·  Elizaveta Kon, MD (3)  ·  Nicolai Bang Foss, Dr.med. (3)  ·  Yoowang Choi, MD (3)

Results publications

PMID 27338778, PMID 31277720, PMID 36269595, PMID 18050189, PMID 23325966, PMID 24907147, PMID 25359382, PMID 25889222, PMID 27432356, PMID 28255449, PMID 31985507, PMID 32025629, PMID 36600185, PMID 36601090, PMID 36931693, PMID 38488976, PMID 39192350, PMID 10776835, PMID 1101375, PMID 11020772, PMID 11354213, PMID 11589257, PMID 11808971, PMID 12098173, PMID 12538372, PMID 15480678, PMID 15534532, PMID 15596866, PMID 15701214, PMID 15712981, PMID 15958159, PMID 15992136, PMID 16083527, PMID 16152868, PMID 16168037, PMID 16271901, PMID 16288617, PMID 16572283, PMID 16651569, PMID 16885182, PMID 17092858, PMID 17159170, PMID 17265499, PMID 17284544, PMID 17310271, PMID 17373192, PMID 17461394, PMID 17464603, PMID 17464604, PMID 17464605

NIH funding

2005 (5), 2014 (5), 2016 (5), 2009 (4), 2017 (4), 2015 (3), 2018 (3), 2008 (2), 2004 (1), 2023 (1), K23AR057578 (1), P60AR047784 (1), R01AR047014 (1), R01AR049762 (1), R01AR050026 (1)